E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/19/2024 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley prices $1.9 million callable contingent income securities on Russell, ETFs

New York, April 19 – Morgan Stanley Finance LLC priced $1.9 million of callable contingent income securities due April 2, 2026 linked to the SPDR S&P Biotech ETF, the SPDR S&P Regional Banking ETF and the Russell 2000 index, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 12.65%, paid quarterly, if each underlier closes at or above its 60% coupon barrier on the related quarterly observation date.

The securities may be called at par on any quarterly call date starting Oct. 3, 2024.

At maturity, the payout will be par unless the worst performing asset finishes below its 55% downside threshold, in which case investors will be fully exposed to the decline of the worst performing asset.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Callable contingent income securities
Underlying assets:SPDR S&P Biotech ETF, SPDR S&P Regional Banking ETF and Russell 2000 index
Amount:$1,902,000
Maturity:April 2, 2026
Coupon:12.65%, paid quarterly, if each underlier closes at or above its 60% coupon barrier on the related quarterly observation date
Price:Par
Payout at maturity:Par unless the worst performing asset finishes below its downside threshold level, in which case investors will be fully exposed to the decline in the worst performing asset
Call option:At par on any quarterly call date starting Oct. 3, 2024
Initial levels:$50.28 for SPDR S&P Regional Banking ETF, 2,124.547 for Russell 2000, $94.89 for SPDR S&P Biotech ETF
Downside thresholds:$27.654 for SPDR S&P Regional Banking ETF, 1,168.501 for Russell 2000, $52.190 for SPDR S&P Biotech ETF, 55% of initial levels
Coupon barriers:$30.168 for SPDR S&P Regional Banking ETF, 1,274.728 for Russell 2000, $56.934 for SPDR S&P Biotech ETF, 60% of initial levels
Pricing date:March 28
Settlement date:April 3
Agent:Morgan Stanley & Co. LLC
Fees:1%
Cusip:61776LLA3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.